T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with NOTCH1 mutation as a good prognostic factor

References

• Bene MC. Biphenotypic, bilineal, ambiguous or mixed lineage: strange leukemias! Haematologica. 2009;94(7):891–893. doi:10.3324/haematol.2009.00779919570749
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):blood-2016-03-643544. doi:10.1182/blood-2016-03-643544
   PubMed Web of Science ®Google Scholar
• Wood BL, Winter SS, Dunsmore KP, Devidas M. T-lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of signifi cance of the early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of end-induction minimal residual disease (MRD) in children’s oncology group (COG). Blood. 2014;124(21):1. 24993873
   PubMed Web of Science ®Google Scholar
• Bond J, Graux C, Lhermitte L, et al. Early response–based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic leukemia study. J Clin Oncol. 2017;35(23):2683–2691. doi:10.1200/JCO.2016.71.858528605290
   PubMed Web of Science ®Google Scholar
• Gutierrez A, Kentsis A. Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy. Br J Haematol. 2018;180(6):919–924. doi:10.1111/bjh.1512929441563
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding L, Holmfeldt L, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481(7380):157–163. doi:10.1038/nature1072522237106
   PubMed Web of Science ®Google Scholar
• Eckstein OS, Wang L, Punia JN, et al. Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. Exp Hematol. 2016;44(8):740–744. doi:10.1016/j.exphem.2016.05.00327208809
   PubMed Web of Science ®Google Scholar
• Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leuk Off J Leuk Soc Am Leuk Res Fund, UK. 1995;9(10):1783–1786. doi:10.1002/cpp.1797
   Google Scholar
• Coustan-Smith E, Mullighan CG, Onciu M, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10(2):147–156. doi:10.1016/S1470-2045(08)70314-019147408
   PubMed Web of Science ®Google Scholar
• Inukai T, Kiyokawa N, Campana D, et al. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99-15. Br J Haematol. 2012;156(3):358–365. doi:10.1111/j.1365-2141.2011.08955.x22128890
   PubMed Web of Science ®Google Scholar
• van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:1901–1928. doi:10.1038/sj.leu.240159210602411
   PubMed Web of Science ®Google Scholar
• Mansur MB, Emerenciano M, Brewer L, et al. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome. Leuk Lymphoma. 2009;50(8):1318–1325. doi:10.1080/1042819090304001419562638
   PubMed Web of Science ®Google Scholar
• Burmeister T, Meyer C, Gröger D, Hofmann J, Marschalek R. Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias. Leuk Res. 2015;39(2):242–247. doi:10.1016/j.leukres.2014.11.01725510485
   PubMed Web of Science ®Google Scholar
• Zenatti PP, Ribeiro D, Li W, et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet. 2011;43(10):932–941. doi:10.1038/ng.92421892159
   PubMed Web of Science ®Google Scholar
• Mansur MB, Hassan R, Barbosa TC, et al. Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia. BMC Cancer. 2012;12(1):9. doi:10.1186/1471-2407-12-922225590
   PubMedGoogle Scholar
• Andrade FG, Noronha EP, Brisson GD, et al. Molecular characterization of pediatric acute myeloid leukemia: results of a multicentric study in Brazil. Arch Med Res. 2016;47(8):656–667. doi:10.1016/j.arcmed.2016.11.01528476193
   PubMed Web of Science ®Google Scholar
• Möricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008. doi:10.1182/blood-2007-09-112920
   PubMed Web of Science ®Google Scholar
• Scrideli CA, Assumpção JG, Ganazza MA, et al. A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups. Haematologica. 2009. doi:10.3324/haematol.2008.003137
   PubMed Web of Science ®Google Scholar
• Alexander TB, Gu Z, Iacobucci I, et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018. doi:10.1038/s41586-018-0436-0
   Web of Science ®Google Scholar
• Patrick K, Wade R, Goulden N, et al. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br J Haematol. 2014;166:421–424. doi:10.1111/bjh.1288224708207
   PubMed Web of Science ®Google Scholar
• Conter V, Valsecchi MG, Buldini B, et al. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis. Lancet Haematol. 2016;3:e80–e86. doi:10.1016/S2352-3026(15)00254-926853647
   PubMed Web of Science ®Google Scholar
• Gutierrez A, Dahlberg SE, Neuberg DS, et al. Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia. J Clin Oncol. 2010;28(24):3816–3823. doi:10.1200/JCO.2010.28.339020644084
   PubMed Web of Science ®Google Scholar
• Zuurbier L, Gutierrez A, Mullighan CG, et al. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged t-cell receptors. Haematologica. 2014;99(1):94–102. doi:10.3324/haematol.2013.09023323975177
   PubMed Web of Science ®Google Scholar
• Wouters BJ, Jorda MA, Keeshan K, et al. Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood. 2007;110(10):3706–3714. doi:10.1182/blood-2007-02-07348617671232
   PubMed Web of Science ®Google Scholar
• Oliveira JL, Kumar R, Khan SP, et al. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion. Pediatr Blood Cancer. 2011;56(3):467–469. doi:10.1002/pbc.2285021225930
   PubMed Web of Science ®Google Scholar
• Matlawska-Wasowska K, Kang H, Devidas M, et al. MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children’s Oncology Group Study. Leukemia. 2016;30(9):1909–1912. doi:10.1038/leu.2016.6026952838
   PubMed Web of Science ®Google Scholar
• Kotrova M, Musilova A, Stuchly J, et al. Distinct bilineal leukemia immunophenotypes are not genetically determined. Blood. 2016;128:2263–2266. doi:10.1182/blood-2016-07-72586127625363
   PubMed Web of Science ®Google Scholar
• Ugale A, Säwén P, Dudenhöffer-Pfeifer M, Wahlestedt M, Norddahl GL, Bryder D. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment. Oncogene. 2017;36(22):3207–3212. doi:10.1038/onc.2016.47028068328
   PubMed Web of Science ®Google Scholar
• Liu Y, Easton J, Shao Y, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017. doi:10.1038/ng.3909
   Web of Science ®Google Scholar
• Mejstrikova E, Volejnikova J, Fronkova E, et al. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria. Haematologica. 2010;95(6):928–935. doi:10.3324/haematol.2009.01450620145275
   PubMed Web of Science ®Google Scholar
• Hrusak O, De Haas V, Stancikova J, et al. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood. 2018:1–12. doi:10.1182/blood-2017-12-821363
   Web of Science ®Google Scholar